FIBROGEN INC — Director's Dealing 2016

Apr 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-04-01

Reporting Person: VALONE FRANK H MD (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-01	Common Stock	M	10750	$3.925	Acquired	115434	Direct
2016-04-01	Common Stock	S	10550	$21.104	Disposed	104884	Direct
2016-04-01	Common Stock	S	200	$21.47	Disposed	104684	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-01	Stock Option (Right to Buy)	$3.925	M	10750	Disposed	2019-08-11	Common Stock (10750)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4000	Indirect

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.

F2: The shares were sold at prices between $20.47 and $21.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Fully vested.